Institutional Review Board (IRB)

Ensuring rights & welfare of human subjects in research

Research conducted by NEOMED using human participants is overseen by the Institutional Review Board (IRB). The primary purpose of the NEOMED IRB is to facilitate the review, approval, modification, and disapproval of research protocols, while ensuring the rights and welfare of human subjects are protected while participating in research.

The IRB process at NEOMED is based on rules and regulations for federally funded research, primarily the Code of Federal Regulation (45 CFR 46) and supporting materials such as the Belmont Report.


IRB Chair: Julie Aultman, Ph.D., ext. 6113
IRB Vice-Chair:  Natalie Bonfine, ext. 6182
Human Protections Administrator: Steve Schmidt, Ph.D., ext. 6290
Committee Coordinator: Trish Wilson, CRA, ext. 6364
Please submit all materials electronically for IRB review to Trish Wilson, CRA, Regulatory Affairs Coordinator,

Meeting Dates

  • January 25, 2021 at 4 p.m.
  • March 08, 2021 at 4 p.m.
  • May 10, 2021 at 4 p.m.
  • July 12, 2021 at 4 p.m.
  • September 13, 2021 at 4 p.m.
  • November 08, 2020 at 4 p.m.


Trish Wilson, CRA
Regulatory Affairs Coordinator
Phone: 330.325.6364

Institutional Review Board (IRB)

Research Administration at NEOMED